Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Revenue of Mosgorlombard for January-October increased by 4.6 times

11/5/24 MGKL

Softline reported for 9 months of 2024 by RAS

11/5/24 SOFL

VK expects to integrate its media services into cars

11/5/24 VKCO

Moscow Exchange summarized the results of trading in October

11/2/24 MOEX

RBC reports for 9 months of 2024 by RAS

11/2/24 RBCM

Shareholders approved the merger of Rosbank with T-Bank

11/2/24 ROSB

Shareholders approved the merger of Rosbank with T-Bank

11/2/24 TCSG

FGC Rosseti reported for 9 months of 2024 by RAS

11/2/24 FEES

Tatneft reported for 9 months of 2024 by RAS

11/2/24 TATN

TNS Energy Group reported for 9 months of 2024 by RAS

11/2/24 TNSE